ROCHESTER, Minn. -
Vyriad, a clinical-stage biotechnology company focused on cancer treatment has just moved to a custom-built facility. It has state-of-the-art labs and offices. The addition got funding from Mayo Clinic, Rochester Area Economic Development and the Southeast Minnesota Capital Fund.
'We developed this technology originally at Mayo Clinic and then when it started to show promise in the clinic, we decided it needed to move into a commercial entity to be further developed," Stephen Russell, the CEO of Vyriad, said.
About 20 people are working in the facilities now but plans to have as many as 50 staffers on the new campus.
Related Content
- Vyriad moves to former IBM complex
- Changes coming to IBM campus
- IBM looking to sell its Rochester property
- IBM sells its location in Rochester
- UPDATE: Auto accident at IBM in Rochester
- IBM's Rochester Campus ranked one of the top lactation rooms in The US
- Rochester woman treated after apartment complex assault
- 82-unit apartment complex proposed in Austin
- Affordable apartment complex proposed in Rochester
- Fire forces evacuation of Rochester apartment complex
Scroll for more content...
